TGF-β2 silencing to target biliary-derived liver diseasesAnne Dropmann, Nadja M. Meindl‐Beinker, T. Dediulia et al.|Gut|2020Cited by 43
Anti-fibrotic and anti-inflammatory consequences of TGF-β2 silencing in biliary liver diseaseAnne Dropmann, NM Meindl-Beinker, Bedair Dewidar et al.|Zeitschrift für Gastroenterologie|2016Cited by 0